Effect of 15-hydroxyprostaglandin dehydrogenase gene on the proliferation of gastric cancer cell murine forestomach carcinoma

Experimental and Therapeutic Medicine

Volumn 7, Issue 1, 2013, Pages 290-294

  Li, Lihua ^a   Yang, Fu ^b   Wang, Xiaojie ^a   Hu, Jing ^a   Yang, Libo ^a   Tang, Chunming ^a   Wu, Yunhua ^a   Miao, Kun ^a   Liu, Rui ^a   Shou, Tao ^a  

^a First People's Hospital of Yunnan Province   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

15 hydroxyprostaglandin dehydrogenase; Gastric; Inhibition; Proliferation; Transfection

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE;

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE GENE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CLONOGENESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSFECTION; MOUSE; NONHUMAN; OPTICAL DENSITY; RECOMBINANT DNA TECHNOLOGY; RECOMBINANT PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA;

EID: 84887891645     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1404     Document Type: Article

References (16)

1. Myung SJ, Rerko RM, Yan M, et al: 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis. Proc Natl Acad Sci USA 103: 12098-12102, 2006.
2. Rao CV, Wang CX, Simi B, et al: Enhancement of experimental colon cancer by genistein. Cancer Res 57: 3717-3722, 1997.
3. Li HL, Jing DD, Lai YX, et al: 15-PGDH is reduced and induces apoptosis and cell cycle arrest in gastric carcinoma. World J Gastroenterol 18: 1028-1037, 2012.
4. Jang TJ, Jeon KH and Jung KH: Cyclooxygenase-2 expression is related to the epithelial-to-mesenchymal transition in human colon cancers. Yonsei Med J 50: 818-824, 2009.
5. Roberts HR, Smartt HJ, Greenhough A, et al: Colon tumour cells increase PGE(2) by regulating COX-2 and 15-PGDH to promote survival during the microenvironmental stress of glucose deprivation. Carcinogenesis 32: 1741-1747, 2011.
6. Sun WH, Zhu F, Chen GS, et al: Blockade of cholecystokinin-2 receptor and cyclooxygenase-2 synergistically induces cell apoptosis and inhibits the proliferation of human gastric cancer cells in vitro. Cancer Lett 263: 302-311, 2008.
7. Liu Z, Wang X, Lu Y, et al: Expression of 15-PGDH is downregulated by COX-2 in gastric cancer. Carcinogenesis 29: 1219-1227, 2008.
8. Moore AE, Greenhough A, Roberts HR, et al: HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells. Carcinogenesis 30: 1796-1804, 2009.
9. +-linked 15-hydroxyprostaglandin dehydrogenase expression. Mol Cancer Ther 8: 3130-3139, 2009.
10. Tseng-Rogenski S, Gee J, Ignatoski KW, et al: Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression. Am J Pathol 176: 1462-1468, 2010.
11. Thiel A, Ganesan A, Mrena J, et al: 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer. Clin Cancer Res 15: 4572-4580, 2009.
12. Yan M, Rerko RM, Platzer P, et al: 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers. Proc Natl Acad Sci USA 101: 17468-17473, 2004.
13. +-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer. Carcinogenesis 26: 65-72, 2005.
14. Song HJ, Myung SJ, Kim IW, et al: 15-hydroxyprostaglandin dehydrogenase is downregulated and exhibits tumor suppressor activity in gastric cancer. Cancer Invest 29: 257-265, 2011.
15. Lou LH, Jing DD, Lai YX, et al: 15-PGDH is reduced and induces apoptosis and cell cycle arrest in gastric carcinoma. World J Gastroenterol 18: 1028-1037, 2012.
16. Na HK, Park JM, Lee HG, et al: 15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy. Biochem Pharmacol 82: 1352-1360, 2011.